Author:
Camuso Natasha,Bajaj Prerna,Dudgeon Deborah,Mitera Gunita
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health (2009) Guidance for industry. use in medical product development to support labeling claims. Rockville, MD, Patient-reported outcome measures
2. Johnson C, Aaronson N, Blazeby JM, Bottomley A, Fayer P, Koller M, Kulis D, Ramage J, Sprangers M, Velikova G, Young T, Group obotEQoL (2011) EORTC Quality of Life Group—Guidelines for Developing Questionnaire Modules. 4th edn
3. Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD (2009) Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Value Health 12(8):1075–1083. doi: 10.1111/j.1524-4733.2009.00603.x
4. Cheville AL, Basford JR, Dos Santos K, Kroenke K (2014) Symptom burden and comorbidities impact the consistency of responses on patient-reported functional outcomes. Arch Phys Med Rehabil 95(1):79–86. doi: 10.1016/j.apmr.2013.08.009
5. Macquart-Moulin G, Viens P, Bouscary ML, Genre D, Resbeut M, Gravis G, Camerlo J, Maraninchi D, Moatti JP (1997) Discordance between physicians’ estimations and breast cancer patients’ self-assessment of side-effects of chemotherapy: an issue for quality of care. Br J Cancer 76(12):1640–1645
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献